FFCP PHASE2:Hg19::chr2:203776344..203776423,-
From FANTOM5_SSTAR
Jump to: navigation, search
| Short description: | p1@WDR12 |
|---|---|
| Species: | Human (Homo sapiens) |
| DPI dataset: | Robust |
| TSS-like-by-RIKEN-classifier(Yes/No): | Yes |
| DHS support(Yes/No): | Yes |
| Description: | CAGE_peak_1_at_WDR12_5end |
| Coexpression cluster: | C1501_hepatocellular_acute_oral_signet_testicular_iPS_teratocarcinoma |
| Association with transcript: | 0bp_to_AK001743, AK022781, AK022782, AK299489_5end |
| EntrezGene: | WDR12 |
| HGNC: | 14098 |
| UniProt: | Q9GZL7B4DRY7 |
| Genome view: | ZENBU |
View on UCSC genome browser
Mouse over to see Genome browser image, Click image to go to Genome browser
CAGE Expression
| Sample | p1@WDR12 |
|---|
0
20
40
60
80
100
120
- Click each plot point to find sample in table
Ontology-based sample term enrichment analysis<b>Summary:</b>This analysis has been performed by utilizing wilcoxon rank sum test.When the number of associated cells/tissues are > n , randomly sampled n cells/tissues are used for P value calculation with rank sum test. this process are repeated several times, and the P values are averaged on the log space <br><b>Analyst:</b> Hideya Kawaji<br><br>link to source dataset<br>data
| Ontology term | p-value | n |
|---|---|---|
| disease of cellular proliferation | 9.81e-44 | 239 |
| cancer | 1.16e-43 | 235 |
| organ system cancer | 1.17e-22 | 137 |
| cell type cancer | 4.97e-21 | 143 |
| hematologic cancer | 1.51e-20 | 51 |
| immune system cancer | 1.51e-20 | 51 |
| leukemia | 2.26e-18 | 39 |
| carcinoma | 3.99e-16 | 106 |
| myeloid leukemia | 1.41e-15 | 31 |
| germ cell and embryonal cancer | 2.49e-08 | 22 |
Showing 1 to 10 of 11 entries
